D-0390-2021 Class II Terminated
FDA drug recall D-0390-2021 was initiated by Lupin Pharmaceuticals Inc. on April 29, 2021 and is designated Class II. Reason for recall: Subpotent Drug The recall status is terminated (terminated February 22, 2022). Affected quantity: 3,138 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- May 26, 2021
- Initiation Date
- April 29, 2021
- Termination Date
- February 22, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,138 bottles
Product Description
Cefixime for Oral Suspension USP 100 mg/5mL, 50mL HDPE bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc. Baltimore, Maryland, 21202 United States, Manufactured by: Lupin Limited, Manddeep, 462 046, India, NDC 68180-405-01
Reason for Recall
Subpotent Drug
Distribution Pattern
Nationwide within the United States
Code Information
Lot #: F900787, Exp. Date 4/2021